BDBM384831 2-(dimethylamino)-N-{(1R)-2-methyl- 1-[4-(trifluoromethyl)phenyl]propyl}- 6-oxo-1,6-dihydropyrimidine-4- carboxamide::US10285989, Example 47

SMILES CC(C)[C@@H](NC(=O)c1cc(=O)[nH]c(n1)N(C)C)c1ccc(cc1)C(F)(F)F

InChI Key InChIKey=TYCVEBDPEOQNAD-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 384831   

TargetPhosphodiesterase(Rhesus macaque)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM384831(2-(dimethylamino)-N-{(1R)-2-methyl- 1-[4-(trifluor...)
Affinity DataKi:  0.430nMAssay Description:The activity of the compounds in accordance with the present invention as PDE2 inhibitors may be readily determined using a fluorescence polarization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
Go to US Patent

TargetcGMP-dependent 3',5'-cyclic phosphodiesterase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM384831(2-(dimethylamino)-N-{(1R)-2-methyl- 1-[4-(trifluor...)
Affinity DataKi:  0.440nMAssay Description:The activity of the compounds in accordance with the present invention as PDE2 inhibitors may be readily determined using a fluorescence polarization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
Go to US Patent